XORTX Therapeutics Inc (XRTX) — Cash Flow Reinvestment Rate

Latest as of December 2020: 0.00x

XORTX Therapeutics Inc (XRTX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2020, reinvesting CA$5.68K (capex CA$2.84K plus investments CA$-2.84K) from operating cash flow of CA$1.57 Million. Check earnings quality score of XORTX Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

CA$5.68K

Capex + Investments

Operating Cash Flow

CA$1.57 Million

CAD

Capital Expenditures

CA$2.84K

CAD

XORTX Therapeutics Inc Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for XORTX Therapeutics Inc across 1 annual periods. Explore XRTX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for XORTX Therapeutics Inc (2017–2017)

Year-by-year capital reinvestment analysis for XORTX Therapeutics Inc. For live market cap and broader valuation context, see XRTX stock market capitalisation.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2017	0.01x	CA$1.17K	CA$91.17K	CA$1.17K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow